SignalRank
SignalRank owns a growing asset portfolio of top performing venture backed companies. It enters at Series B by helping early stage investors maintain their ownership in their best assets. The resulting portfolio is a top decile venture performer since inception in May 2023. SignalRank finances early stage investors’ pro-rata in qualifying Series B rounds through an automated process designed for speed, high-conviction selection, and partner-aligned economics. it can decide inside 24 hours and fund in less than a week. As a result SignalRank has 300+ seed partners who invite it to partner for pro-rata financing in their fastest growing companies. It sees a high percentage of all Series B term sheets prior to close. Capital is supplied from SignalRank’s balance sheet, with no capital calls or partner IC process delays. Check size correlates with capital available. SignalRank handles SPV setup and ongoing administration, with a target of moving from partner allocation request to funding in 5 business days. 20% of the profit on each investment goes directly to partners. SignalRank creates deal-by-deal SPVs; SignalRank does not charge management fees for this partner product. The portfolio can be seen at - https://signalrank.com/signalrank-index.html
SignalRank owns a growing asset portfolio of top performing venture backed companies. It enters at Series B by helping early stage investors maintain their ownership in their best assets. The resulting portfolio is a top decile venture performer since inception in May 2023. SignalRank finances early stage investors’ pro-rata in qualifying Series B rounds through an automated process designed for speed, high-conviction selection, and partner-aligned economics. it can decide inside 24 hours and fund in less than a week. As a result SignalRank has 300+ seed partners who invite it to partner for pro-rata financing in their fastest growing companies. It sees a high percentage of all Series B term sheets prior to close. Capital is supplied from SignalRank’s balance sheet, with no capital calls or partner IC process delays. Check size correlates with capital available. SignalRank handles SPV setup and ongoing administration, with a target of moving from partner allocation request to funding in 5 business days. 20% of the profit on each investment goes directly to partners. SignalRank creates deal-by-deal SPVs; SignalRank does not charge management fees for this partner product. The portfolio can be seen at - https://signalrank.com/signalrank-index.html
SignalRank has raised $26.5M across 1 round. Its most recent round was a Series A of $26.5M in Jun 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
SignalRank is featured in
Similar companies
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Global Sales Tax Compliance Software
Derya is an AI-native freight-forwarding/logistics software company that provides an AI workbench for freight forwarders and related content.
TIFIN is a platform that conceives, creates, and operates fintech companies in the areas of wealth management, investments, and personal finance. Their operating companies are shaping the future of investor experience with intelligent products that recognize the uniqueness of each investor. TIFIN leverages the combined power of investment intelligence, data science, and technology to make investing a more powerful driver of financial well-being.
8090 Solutions provides an AI-native software development platform through Software Factory, a system designed to help teams manage the software development lifecycle from planning to deployment. The platform connects business requirements, architecture planning, implementation tasks, testing, and feedback within a shared workspace using AI-driven workflows and knowledge management. 8090 Solutions enables organizations to coordinate product, engineering, and business teams while maintaining visibility across software projects. The company’s solutions support custom software development, AI-assisted engineering processes, and enterprise software delivery through structured collaboration between teams and AI agents.
Developers no longer have to manually piece together the impact of pull requests; Baz models, analyzes and reviews code changes, detecting breaking changes, enforcing consistency, and highlighting misaligned coding patterns. Baz makes every review faster, more accurate, and aligned with the real-world impact of the code changes being made.
Eccentric Machines is a manufacturer of robotic actuator technology enabling advanced motion control for embodied AI systems.
EIS Automation provides modular automation and robotic solutions for manufacturing.
Pocket is a technology company that develops an AI-enabled note-taking system combining a dedicated recording device with companion software. Its platform records in-person conversations and phone calls, transcribes audio, and organizes the content into searchable transcripts, summaries, action items, and mind maps. The system supports offline recording, cloud synchronization, and access across mobile, desktop, and web applications, with support for more than 120 languages. Pocket also provides AI-powered features for organizing, searching, and exporting recorded information while offering integrations with task management workflows. Its products are designed for individuals and teams who need to capture, organize, and retrieve information from conversations and spoken ideas.
Straiker builds AI-native security solutions tp protect customers from a spectrum of security & safety risks.
Engine Biosciences is a biotech company that uses machine learning to study genomics for the purpose of drug discovery. They are a technology company based in both San Francisco and Asia that is funded by investors. They specialize in network biomedicine and have developed their own patented technologies that involve extensive laboratory experimentation and artificial intelligence algorithms. These technologies are used for both drug discovery and cellular reprogramming. The company's research and development platform, which was created by a team of esteemed scientists and professors from universities such as MIT and Harvard, significantly speeds up and reduces the cost of developing new medical treatments. Engine Biosciences actively utilizes this platform internally and collaborates with partners in various disease areas.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.